Purpose

The Accuryn Registry Study is an open-ended, global, multi-center, retrospective and prospective, single-arm data collection study with an FDA cleared device. The target population are cardiovascular surgery patients. Physiologic data measurements will be collected from enrolled subjects using electronic medical records and data streams via the Accuryn Monitoring System.

Conditions

Eligibility

Eligible Ages
Over 18 Years
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  1. Signed or Verbal Informed Consent as required by IRB (if applicable). 2. Adult (age ≥ 18). 3. Monitored on the Accuryn® Monitoring System during their procedure and ICU stay (for retrospective enrollment). 4. Patient is undergoing cardiac surgical intervention(s).

Exclusion Criteria

  1. Known history of advanced chronic kidney disease defined by an estimated glomerular filtration rate (eGFR) <20 mL/min/1.73m2 within 30 days prior to procedure. 2. The patient is unsuitable for the study, in the opinion of the investigator. This may include vulnerable patient populations such as pregnant women, prisoners ,or those detained in a penal institution.

Study Design

Phase
Study Type
Observational
Observational Model
Case-Only
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Accuryn Monitoring System Observational only (no intervention). Patients undergoing cardiovascular surgical intervention(s) monitored with the Accuryn Monitoring System (per standard of care) during their hospital stay
  • Device: Accuryn Monitoring System
    The Accuryn Monitoring System is a novel Foley catheter and monitoring device capable of detecting physiologic changes in vital signs via sensors within the catheter system. These data are captured non-invasively, continuously, and at a high frequency.

Recruiting Locations

George Washington University Hospital
Washington D.C. 4140963, District of Columbia 4138106 20037
Contact:
Gage Parr, MD
202-715-4000
KPARR@mfa.gwu.edu

Cleveland Clinic Florida
Weston 4178003, Florida 4155751 33331
Contact:
Steven Minear, MD
954-290-1569
minears@ccf.org

Jewish Hospital / University of Louisville
Louisville 4299276, Kentucky 6254925 40202
Contact:
Terry Blanton, BSN, RN
502-587-4381
mary.blanton@louisville.edu

Mission Health Hospital
Asheville 4453066, North Carolina 4482348 28803
Contact:
Leslie McPeters, MSN, FNP
828-213-5679
leslie.mcpeters@hcahealthcare.com

Duke University Hospital
Durham 4464368, North Carolina 4482348 27710
Contact:
Madhav Swaminathan, MD
919-681-6532
madhav.swaminathan@duke.edu

Cleveland Clinic
Cleveland 5150529, Ohio 5165418 44195
Contact:
Michael Kot, MD
216-442-6616
kotm@ccf.org

More Details

Status
Recruiting
Sponsor
Potrero Medical

Study Contact

Bev Ann Blackwell
256-679-5422
bblackwell@potreromed.com

Detailed Description

The primary objective of the Accuryn Registry Study is to is to track and analyze changes in physiologic data streams using the Accuryn Monitoring System and correlate these changes to the occurrence of acute kidney injury (AKI) following cardiac surgical intervention(s). The secondary objective is to determine the incidence of intraoperative and postoperative intra-abdominal hypertension in the cardiovascular surgery population, analyze what factors may contribute to the development of intra-abdominal hypertension (IAH) in this patient population, and analyze associations of IAH with organ dysfunctions such as acute kidney injury and other clinical outcomes (e.g. ICU length of stay, required hemodialysis, readmission).

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.